Institutional Collaborators

These academic healthcare facilities will contribute outstanding cardiovascular research excellence and clinical capabilities to the GCIC to promote the commercialization of new products and the creation of new companies.

Cleveland Clinic

The Cleveland Clinic, located in Cleveland, Ohio, is a not-for-profit, multi-specialty academic medical center that integrates clinical and hospital care with research and education. The Cleveland Clinic is one of the largest and most respected hospitals in the country. Cleveland Clinic’s widely recognized technology commercialization arm, CCF Innovations, was established in 2000 to lead CCF’s strong commitment to discovery and innovation. CCFI commercializes all inventions and related technology throughout CCF and will manage GCIC commercialization. Its comprehensive approach includes a wide scope of supporting activities, infrastructures, and expertise.
www.clevelandclinic.org

Case Western Reserve University

Case Western Reserve University, of Cleveland, Ohio, is among the nation's leading research institutions. Case offers nationally recognized programs in the Dental Medicine, Engineering, Law, Management, Medicine, Nursing, and Social Work. Case Western Reserve holds membership in the Association of American Universities, and is accredited by the Higher Learning Commission of the North Central Association of Colleges and Schools.
www.case.edu

University Hospitals (UH)

UH is part of the University Hospitals Health System, which is comprised of the Cleveland campus of hospitals and 13 community hospitals in Northeast Ohio with an integrated network of physicians. The Cleveland facility includes Rainbow Babies & Children’s Hospital, among the nation’s best pediatric hospitals; Ireland Cancer Center, northern Ohio’s only National Cancer Institute designated Comprehensive Cancer Center, and MacDonald Women’s Hospital, Ohio’s only hospital dedicated to women’s health. UH is a close affiliate of the Case Western Reserve University School of Medicine, with researchers and clinicians from UH leading the teaching of the medical school students.
www.uhhospitals.org

Ohio State University

The Ohio State University is rated by The National Science Foundation among the top ten public research universities in the country. Like other in the GCIC consortia, Ohio State has built capabilities to bring its research efforts into commercialized products. Specifically, the GCIC will benefit from the expertise and research acumen of Drs. L. James Lee, Doug Kniss and John Lannutti from the Ohio State University’s NSEC Center for Affordable Nanoengineering of Polymeric Biomedical Devices.
www.osu.edu

University of Toledo

University of Toledo – The Center for Drug Design and Development (CD3) is a Board approved component of the core research infrastructure within The University of Toledo (UT) College of Pharmacy. The CD3 occupies several laboratories that can be divided into four major functions: drug design and computational chemistry, synthetic medicinal chemistry, analytical and bioanalytical chemistry and biological testing. This lab is capable of conducting molecular biology manipulations, biochemical and cell culture assays, small animal in vivo studies, and all aspects of drug absorption, distribution, metabolism, excretion and toxicity testing associated with the translation of a new therapeutic or diagnostic concept across small molecule preclinical drug development. While all of these translational resources are specialized toward the development of small molecule drug and therapeutic agents, they can literally be applied across any therapeutic class including that of cardiovascular.
www.utoledo.edu

University of Cincinnati

The University of Cincinnati and Cincinnati Children’s Hospital have collectively become an international leader in cardiac research. The collaborative environment between cardiac researchers from different departments has earned many cardiovascular grants. The Cardiovascular Research Center provides UC with state-of-the-art laboratories, equipment and classrooms in which researchers and educators can find the cellular and genetic causes of heart disease. Cardiac research is broadly focused upon the “normal” versus “diseased” growth of the heart and vasculature. UC was named a Specialized Center of Research in Heart Failure, sponsored by the NIH through 2004 and more recently, awarded a SCCOR grant from the NIH to continue studies on cardiovascular disease. The UC Medical Center is a major referral center for patients requiring cardiac care and heart transplantation. University Hospital operates state-of-the-art cardiovascular diagnostic laboratories and a heart-failure transplantation clinic. UC’s College of Medicine is ranked 42nd amongst all medical schools in NIH funding while the University is ranked 24th amongst all public universities in federal research and development expenditures.
www.uc.edu